Research-Grade Topical Antibiotic Solution
Ciplox Eye/Ear Drops 0.3% is a topical ciprofloxacin antibiotic solution manufactured by Cipla for in-vitro research applications. This ophthalmic and otic preparation contains 0.3% ciprofloxacin hydrochloride, a second-generation fluoroquinolone antibiotic extensively studied in antimicrobial research protocols. Researchers investigating topical antibiotic formulations will find this solution valuable for examining ciprofloxacin’s broad-spectrum activity against gram-positive and gram-negative bacterial strains. The sterile formulation allows controlled laboratory investigation of antimicrobial efficacy, bacterial resistance patterns, and pharmaceutical delivery mechanisms in ocular and auricular tissue models.
Laboratory Research Applications
Ciprofloxacin demonstrates significant research utility in antimicrobial studies, particularly for investigating bacterial DNA gyrase inhibition mechanisms. Laboratory protocols frequently examine this fluoroquinolone’s activity against Pseudomonas aeruginosa, Staphylococcus aureus, and other clinically relevant pathogens in controlled research environments. The 0.3% concentration enables researchers to evaluate minimum inhibitory concentrations, bacterial kill kinetics, and resistance development patterns. Studies investigating ocular pharmacokinetics benefit from this standardised formulation for examining drug penetration, tissue distribution, and elimination pathways. Our Stroid UK Shop maintains comprehensive quality documentation supporting laboratory investigations. Researchers studying antimicrobial peptide interactions or examining combination therapy approaches will find this ciprofloxacin solution essential for comparative efficacy studies alongside compounds from our antibacterial drugs collection.
Product Specifications
| Parameter | Specification |
|---|---|
| Active ingredient | Ciprofloxacin hydrochloride 0.3% |
| CAS number | 86393-32-0 |
| Molecular formula | C₁₇H₁₈FN₃O₃·HCl |
| Molecular weight | 367.80 g/mol |
| Manufacturer | Cipla Limited |
| Storage conditions | Room temperature, protect from light |
Each sterile solution undergoes rigorous pharmaceutical manufacturing controls ensuring consistent research-grade quality. The formulation includes appropriate preservatives and buffering agents maintaining stability throughout investigational protocols. Researchers requiring alternative research compounds may explore our SARMS or peptides collections for complementary laboratory studies.
Research Compliance Statement
This product is manufactured exclusively for in-vitro research purposes and laboratory investigations. Ciplox Eye/Ear Drops 0.3% is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional oversight, safety protocols, and waste disposal procedures when handling this antimicrobial solution. All studies should comply with relevant research ethics guidelines and institutional biosafety requirements for antimicrobial compound investigations.
